Dr. Yohannes T. Ghebre is Associate Professor and Director of Radiation Biology Laboratory in the Department of Radiation Oncology at Baylor College of Medicine (BCM). Before joining BCM, Dr. Ghebre was Assistant Professor of Cardiovascular Sciences at the Houston Methodist Research Institute (HMRI) with a joint appointment as an Assistant Professor of Pharmacology at Weill Cornell Medical College (WCMC). Prior to Methodist, he received extensive training at Stanford University, School of Medicine.
During his 6 years of training at Stanford University, Dr. Ghebre made substantial contribution towards our understanding of endogenous and exogenous factors that regulate the nitric oxide synthase (NOS) pathway including their influence on the vascular endothelial system. In addition, he has made important contribution in the discovery and characterization of small molecules that modulate nitric oxide levels in the settings of tissue inflammation and fibrosis. In this regard, his work with Proton Pump Inhibitors (PPIs) has been featured in International Media outlets including The Wall Street Journal; Forbes Magazine; The New York Times; Washington Post; The Guardian; Science Daily; Daily Mail (UK); and Front Page of the Houston Chronicle.
For his scientific excellence, Dr. Ghebre has received numerous awards including two merit-based postdoctoral fellowships, the Caroline Wiess Law Translational Research Grant, and merit-based grants from the American Heart Association (AHA) and the National Institutes of Health (NIH). Dr. Ghebre currently runs an NIH-supported laboratory at Baylor College of Medicine to evaluate the efficacy of candidate small molecules in mitigating tissue inflammation and fibrosis. Dr. Ghebre has published over 30 peer-reviewed articles, reviews, editorials and book chapters which have been collectively cited over 1,000 times.
In addition to his research duties, Dr. Ghebre is involved in several academic activities including education, service in committees including with the American Thoracic Society, and peer review of manuscripts and grants. He is also a fellow of the American Heart Association (FAHA).
As a scientist-entrepreneur, Dr. Ghebre is Co-Founder and Advisory Committee Member of PhaRNA, LLC.